Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination ...
8d
PsyPost on MSNSemaglutide reduces brain inflammation and improves memory in an Alzheimer’s modelA new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...
Epstein-barr virus aggravates ulcerative colitis via macrophage pyroptosis: a new therapeutic target
A recent study has revealed how Epstein-Barr virus (EBV) intensifies ulcerative colitis (UC), a debilitating inflammatory ...
Mast cells, which are abundant in the airways of asthmatic individuals, act as first responders to viral infections by ...
The company’s Phase III trial of nemvaleukin alfa alongside Keytruda saw just a 0.3 month gain in overall survival over other ...
The loss of muscle mass and strength poses an increasingly significant challenge for an aging society. Prof. Kristina ...
A recent study has revealed how Epstein-Barr virus (EBV) intensifies ulcerative colitis (UC), a debilitating inflammatory ...
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...
4d
MedPage Today on MSNNewer Biologics Tied to Fewer Infections for Older Patients With Psoriatic DiseaseBiologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results